CAPTRUST Financial Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-18,045
Closed -$243K – 2488
2023
Q4
$243K Sell
18,045
-8,453
-32% -$99.3K ﹤0.01% 2255
2023
Q3
$341K Sell
26,498
-6,578
-20% -$118K ﹤0.01% 1912
2023
Q2
$597K Buy
+33,076
New +$618K ﹤0.01% 1522
2022
Q3
– Sell
-1,163
Closed -$27K – 3379
2022
Q2
$27K Sell
1,163
-408
-26% -$11.7K ﹤0.01% 3198
2022
Q1
$51K Buy
1,571
+329
+26% +$10.6K ﹤0.01% 2769
2021
Q4
$39K Buy
1,242
+29
+2% +$969 ﹤0.01% 2857
2021
Q3
$46K Buy
1,213
+391
+48% +$15.6K ﹤0.01% 2633
2021
Q2
$33K Buy
822
+5
+0.6% +$211 ﹤0.01% 2778
2021
Q1
$35K Buy
817
+787
+2,623% +$34.7K ﹤0.01% 2661
2020
Q4
$1K Hold
30
– – ﹤0.01% 3287
2020
Q3
$1K Buy
+30
New +$931 ﹤0.01% 2931

Other funds holding OFIX

CAPTRUST Financial Advisors's OFIX Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Orthofix Medical (OFIX) in Q1 2024, closing a stake of 18,045 shares — an estimated $243K sold.

CAPTRUST Financial Advisors first reported a position in OFIX in Q3 2020 and held it in 11 quarters. The position peaked at $597K in Q2 2023. 136 funds tracked by Wall St. Rank hold OFIX as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Orthofix Medical position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 18,045 Orthofix Medical shares in Q1 2024, an estimated $243K.
  • CAPTRUST Financial Advisors first reported a position in Orthofix Medical in Q3 2020 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Orthofix Medical position peaked at $597K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.